div class=trans-pagebuttonPage 1button div class=trans-image amp-img class=trans-thumb alt=Page 1: Presentazione di PowerPoint - overgroupeu · IDENTIFICAZIONE CA PROSTATA INDICAZIONI E RISULTATI 95% co % THE LANCET Figure S2 — Proportion of men with no cancer insignificant src=https:reader031fdocumentsnetreader031viewer20220227185c5bfa7009d3f236368cad22html5thumbnails1jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 2button div class=trans-image amp-img class=trans-thumb alt=Page 2: Presentazione di PowerPoint - overgroupeu · IDENTIFICAZIONE CA PROSTATA INDICAZIONI E RISULTATI 95% co % THE LANCET Figure S2 — Proportion of men with no cancer insignificant src=https:reader031fdocumentsnetreader031viewer20220227185c5bfa7009d3f236368cad22html5thumbnails2jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 3button div class=trans-image amp-img class=trans-thumb alt=Page 3: Presentazione di PowerPoint - overgroupeu · IDENTIFICAZIONE CA PROSTATA INDICAZIONI E RISULTATI 95% co % THE LANCET Figure S2 — Proportion of men with no cancer insignificant src=https:reader031fdocumentsnetreader031viewer20220227185c5bfa7009d3f236368cad22html5thumbnails3jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 4button div class=trans-image amp-img class=trans-thumb alt=Page 4: Presentazione di PowerPoint - overgroupeu · IDENTIFICAZIONE CA PROSTATA INDICAZIONI E RISULTATI 95% co % THE LANCET Figure S2 — Proportion of men with no cancer insignificant src=https:reader031fdocumentsnetreader031viewer20220227185c5bfa7009d3f236368cad22html5thumbnails4jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 5button div class=trans-image amp-img class=trans-thumb alt=Page 5: Presentazione di PowerPoint - overgroupeu · IDENTIFICAZIONE CA PROSTATA INDICAZIONI E RISULTATI 95% co % THE LANCET Figure S2 — Proportion of men with no cancer...